Artificial intelligence-based volumetric measurements for longitudinal clinical assessment of treatment response in high-grade gliomas: Validation across institutional and public datasets
Neuro-Oncology Advances · 12.01.2026 · 8 (1)
DOI: 10.1093/noajnl/vdag045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 17.02.2026. Verfasst von Zerubabbel K Asfaw und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York City. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
High-grade gliomas (HGGs) require ongoing imaging to guide treatment, traditionally relying on labor-intensive and variable manual MRI measurements. While FDA-cleared artificial intelligence (AI) tools offer automated tumor volume segmentation, their clinical utility in decision-making remains understudied. This study assesses the utility and limitations of an FDA-cleared AI-based tool across public and institutional datasets, comparing its output with multidisciplinary tumor board (MDTB) assessments.
Methods
We applied the FDA-cleared, AI-based tool Neosoma HGG to quantify tumor volumes in 214 subjects from public datasets and 49 from an institutional cohort. AI-derived volumes were compared to expert manual and other AI-based measurements. Therapeutic response assessments using RANO criteria were evaluated against MDTB diagnoses. Segmentation times were analyzed using mixed-model regression.
Results
We analyzed 1648 MRI sequences of 95 HGG patients across three datasets. Contrast-enhancing (CE) tumor volumes were consistent across AI platforms, and Neosoma HGG significantly reduced segmentation time (pre-operative: 210.5s, post-operative: 179s vs. 15 s, P < .0001). AI-informed disease state assessments showed an overall moderate agreement with MDTB diagnoses for progressive disease (k = 0.45, P < .00001). Key discrepancies arose from limitation of Neosoma HGG in distinguishing pseudo-progression from tumor progression. T2-FLAIR-derived volumes varied significantly between AI platforms (P < .001), with discordances largely due to over-segmentation beyond the tumor region.
Conclusion
AI-based volumetric segmentation has the potential to improve efficiency and standardization in monitoring HGG, especially for CE tumor burden. However, moderate concordance with MDTB assessments and difficulties with FLAIR imaging underscore its current limitations. AI should serve as a clinical decision support tool, with further refinement needed to improve specificity and integrate multimodal imaging data.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York City.
- Department of Surgery, University of Alabama at Birmingham, Birmingham.
- Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City.
- Department of Radiology, Icahn School of Medicine at Mount Sinai, New York City.
ORCID-Profile: Zerubabbel K Asfaw, Isabelle M Germano
Zitieren
APA
Asfaw, Z. K., Young, T., Hernandez Marquez, G., Brown, C., Tomalin, L. E., Belani, P., Doshi, A., & Germano, I. M. (2026). Artificial intelligence-based volumetric measurements for longitudinal clinical assessment of treatment response in high-grade gliomas: Validation across institutional and public datasets. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag045
Vancouver
Asfaw ZK, Young T, Hernandez Marquez G, Brown C, Tomalin LE, Belani P, et al. Artificial intelligence-based volumetric measurements for longitudinal clinical assessment of treatment response in high-grade gliomas: Validation across institutional and public datasets. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag045
BibTeX
@article{Asfaw2026,
author = {Asfaw, Zerubabbel K and Young, Tirone and Hernandez Marquez, Gianina and Brown, Cole and Tomalin, Lewis E and Belani, Puneet and Doshi, Amish and Germano, Isabelle M},
title = {Artificial intelligence-based volumetric measurements for longitudinal clinical assessment of treatment response in high-grade gliomas: Validation across institutional and public datasets},
journal = {Neuro-Oncology Advances},
year = {2026},
volume = {8},
number = {1},
doi = {10.1093/noajnl/vdag045}
}
EUVIMED